Privi Speciality Chemicals Reports Financial Results and Recommends Dividend for FY 2025-26

Privi Speciality Chemicals Reports Financial Results and Recommends Dividend for FY 2025-26​

Privi Speciality Chemicals Limited announced the outcomes of its Board Meeting held on May 11, 2026, disclosing its audited financial results for the quarter and financial year ended March 31, 2026. The board also recommended a final dividend and approved key appointments regarding the company's corporate governance structure.

Financial Performance Overview​

The company disclosed both standalone and consolidated financial results for the year ended March 31, 2026.

Consolidated Financial Highlights
The consolidated financial results reflect the performance of the Group for the year ended March 31, 2026.

• Total Income reached Rs. 2,56,368.55 lakhs.
• The Net profit attributable to the Owners of the Holding Company stood at Rs. 32,853.55 lakhs.
• The total assets of the Group stood at Rs. 3,16,982.01 lakhs.

Standalone Financial Highlights
For the standalone entity, total income for the year ended March 31, 2026, was Rs. 2,47,241.46 lakhs. The net profit for the year was Rs. 35,744.19 lakhs. As of March 31, 2026, the company's total assets were Rs. 2,88,309.87 lakhs.

The key financial data for the standalone entity is summarized below:

Dividend and General Meeting Details​

The board recommended a final dividend of Rs. 10/- (100%) per Equity Share, with a face value of Rs. 10/- each, for the financial year 2025-26. This dividend is subject to the approval of the shareholders at the ensuing 41st Annual General Meeting (AGM).

The key dates related to the shareholder meeting and dividend payout are as follows:

• Annual General Meeting: Friday, August 7, 2026.
• Record Date for Dividend: Friday, July 31, 2026.
• Payment Timeline: The dividend, if approved by the shareholders, will be paid within 30 days from the date of the 41st AGM.
• Record Book Closure: The Register of Members and Share Transfers Book will be closed from Saturday, August 1, 2026, through Friday, August 7, 2026.

Corporate Governance and Key Appointments​

The board took several actions related to directorships and professional appointments:

1. Director Re-appointment: The board re-appointed Mr. Bhaktavatsala Rao Doppalapudi as an Executive Director (Whole-time Director) for a period of three consecutive years. His tenure is effective from August 1, 2026, up to August 12, 2029. Mr. Rao was noted to have been associated with the Privi group since 1992 and is the Managing Director of Privi Biotechnologies Private Limited, a wholly owned subsidiary.
2. Auditor Re-appointment: The company re-appointed M/s. Aneja Associates, Chartered Accountants, as the Internal Auditor for the Financial Year 2026-27.
3. Cost Auditor Appointment: M/s. Kishore Bhatia & Associates was re-appointed as the Cost Auditors of the company for the Financial Year 2026-27.

Audit Reports​

The company received an unmodified audit opinion from its statutory auditors regarding both the standalone and consolidated annual financial results for the year ended March 31, 2026. The audit reports confirmed that the financial results provide a true and fair view in conformity with applicable Indian Accounting Standards.

PRIVISCL Stock Price Movement​

Today, Privi Speciality Chemicals Limited shares edged higher, settling at ₹3549.7 after posting a strong gain of 1.77%. The stock traded on a robust volume of 179,310 shares, making a notable run that brought it close to its 52-week high of ₹3590.9.